Cargando…
Aβ42 oligomer-specific antibody ALZ-201 reduces the neurotoxicity of Alzheimer’s disease brain extracts
BACKGROUND: In Alzheimer’s disease (AD), amyloid-β 1–42 (Aβ42) neurotoxicity stems mostly from its soluble oligomeric aggregates. Studies of such aggregates have been hampered by the lack of oligomer-specific research tools and their intrinsic instability and heterogeneity. Here, we developed a mono...
Autores principales: | Sandberg, Anders, Berenjeno-Correa, Ernesto, Rodriguez, Rosa Crespo, Axenhus, Michael, Weiss, Sophia Schedin, Batenburg, Kevin, Hoozemans, Jeroen J. M., Tjernberg, Lars O., Scheper, Wiep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798723/ https://www.ncbi.nlm.nih.gov/pubmed/36578089 http://dx.doi.org/10.1186/s13195-022-01141-1 |
Ejemplares similares
-
Proteomics Time-Course Study of App Knock-In Mice Reveals Novel Presymptomatic Aβ(42)-Induced Pathways to Alzheimer’s Disease Pathology
por: Schedin-Weiss, Sophia, et al.
Publicado: (2020) -
Changes in dementia diagnoses in Sweden during the COVID-19 pandemic
por: Axenhus, Michael, et al.
Publicado: (2022) -
The unfolded protein response in neurodegenerative diseases: a neuropathological perspective
por: Scheper, Wiep, et al.
Publicado: (2015) -
Neuronal Aβ42 is enriched in small vesicles at the presynaptic side of synapses
por: Yu, Yang, et al.
Publicado: (2018) -
Microdissected Pyramidal Cell Proteomics of Alzheimer Brain Reveals Alterations in Creatine Kinase B-Type, 14-3-3-γ, and Heat Shock Cognate 71
por: Sandebring-Matton, Anna, et al.
Publicado: (2021)